Terms: = Endocrine gland cancer AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997 AND Treatment
24913 results:
1. Integrated analysis identified the role of three family members of ARHGAP in pancreatic adenocarcinoma.
Fei H; Shi X; Sun D; Yang H; Wang D; Li K; Si X; Hu W
Sci Rep; 2024 May; 14(1):11790. PubMed ID: 38783033
[TBL] [Abstract] [Full Text] [Related]
2. Pharmacogenomic analysis in adrenocortical carcinoma reveals genetic features associated with mitotane sensitivity and potential therapeutics.
Zhang J; Wu L; Su T; Liu H; Jiang L; Jiang Y; Wu Z; Chen L; Li H; Zheng J; Sun Y; Peng H; Han R; Ning G; Ye L; Wang W
Front Endocrinol (Lausanne); 2024; 15():1365321. PubMed ID: 38779454
[TBL] [Abstract] [Full Text] [Related]
3. Surgical outcomes of robotic thyroidectomy for thyroid tumors over 4 cm via the bilateral axillo-breast approach.
Bae HL; Wong JS; Kim SJ; Jung Y; Choi JB; Kwak J; Yu HW; Chai YJ; Choi JY; Lee KE
Sci Rep; 2024 May; 14(1):11646. PubMed ID: 38773181
[TBL] [Abstract] [Full Text] [Related]
4. Construction and Validation of a Nomogram to Predict the Postoperative Venous Thromboembolism Risk in Patients with HGSOC.
Huang Z; Li L; Gong Z; Tang L
Clin Appl Thromb Hemost; 2024; 30():10760296241255958. PubMed ID: 38767088
[TBL] [Abstract] [Full Text] [Related]
5. Curcumin affects autophagy of prolactinoma cells by upregulating miR-206 to exert antitumor effects.
Duan JF; Zhang QJ; Zhu J; Lu JH
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23734. PubMed ID: 38764151
[TBL] [Abstract] [Full Text] [Related]
6. Assessment of secular trends of three major gynecologic cancers burden and attributable risk factors from 1990 to 2019: an age period cohort analysis.
Liu Y; Shi W; Mubarik S; Wang F
BMC Public Health; 2024 May; 24(1):1349. PubMed ID: 38764017
[TBL] [Abstract] [Full Text] [Related]
7. Palliative treatment of generalized metastatic follicular carcinoma of thyroid after operation: A case report and literature review.
Zhao H; Kang W; Guan J; Wang Y
Medicine (Baltimore); 2024 May; 103(20):e38237. PubMed ID: 38758843
[TBL] [Abstract] [Full Text] [Related]
8. Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors.
Lin AL; Rudneva VA; Richards AL; Zhang Y; Woo HJ; Cohen M; Tisnado J; Majd N; Wardlaw SL; Page-Wilson G; Sengupta S; Chow F; Goichot B; Ozer BH; Dietrich J; Nachtigall L; Desai A; Alano T; Ogilive S; Solit DB; Bale TA; Rosenblum M; Donoghue MTA; Geer EB; Tabar V
Acta Neuropathol; 2024 May; 147(1):85. PubMed ID: 38758238
[TBL] [Abstract] [Full Text] [Related]
9. Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification.
Huai M; Wang Y; Li J; Pan J; Sun F; Zhang F; Zhang Y; Xu L
J Nanobiotechnology; 2024 May; 22(1):257. PubMed ID: 38755645
[TBL] [Abstract] [Full Text] [Related]
10. Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian cancer: Findings From Cohort A of the OPAL Phase II Trial.
Liu JF; Gaillard S; Wahner Hendrickson AE; Yeku O; Diver E; Gunderson Jackson C; Arend R; Ratner E; Samnotra V; Gupta D; Chung J; Zhang H; Compton N; Baines A; Bacqué E; Liu X; Felicetti B; Konecny GE
JCO Precis Oncol; 2024 May; 8():e2300693. PubMed ID: 38754056
[TBL] [Abstract] [Full Text] [Related]
11. Feasibility and cost-effectiveness of genetic counselling for all patients with newly diagnosed ovarian cancer: a single-centre retrospective study.
Schlootz S; Saner FAM; Rabaglio M; Imboden S; Wampfler J
Swiss Med Wkly; 2024 Apr; 154():3386. PubMed ID: 38754016
[TBL] [Abstract] [Full Text] [Related]
12. Safety and efficacy of peptide receptor radionuclide therapy in neuroendocrine tumors: A single center experience.
Sukrithan V; Armbruster H; Rogers S; Vogt SM; Grenade C; Verschraegen C; Zhou Y; Goyal A; Natwa M; Hussein A; Barr H; Konate D; Batdorf R; Brown A; Williams B; Zhao S; Wei L; Xu M; Shah MH; Konda B
PLoS One; 2024; 19(5):e0298824. PubMed ID: 38748739
[TBL] [Abstract] [Full Text] [Related]
13. The Role of Palliative Surgery in the Management of Acute Intestinal Obstruction Secondary to Peritoneal Carcinomatosis.
Bhat BK; Yadav A; Nundy S
Chirurgia (Bucur); 2024 Apr; 119(2):218-226. PubMed ID: 38743835
[No Abstract] [Full Text] [Related]
14. Impact on Long-term Survival of a Standardized Histopathological Protocol on the R1 Incidence in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma.
Moiş E; Graur F; Puia C; Vlad I; Moldovan S; Ursu CP; Nechita VI; Vălean D; Furcea L; Puia A; Zaharie F; Popa C; Bodea R; Iancu C; Rusu I; Hajjar NA
Chirurgia (Bucur); 2024 Apr; 119(2):171-183. PubMed ID: 38743830
[No Abstract] [Full Text] [Related]
15. Differentially expressed genes associated with high metabolic tumor volume served as diagnostic markers and potential therapeutic targets for pancreatic cancer.
Kim BG; Lee SH; Jang Y; Kang S; Kang CM; Cho NH
J Transl Med; 2024 May; 22(1):453. PubMed ID: 38741142
[TBL] [Abstract] [Full Text] [Related]
16. [A rare cause of hypercorticism: ACTH-secreting pheochromocytoma (a case report)].
Rifai K; Toulali F; Iraqi H; Ettaik M; Gharbi MEH
Pan Afr Med J; 2024; 47():88. PubMed ID: 38737225
[TBL] [Abstract] [Full Text] [Related]
17. The influence of delayed gastric emptying on quality of life after partial duodenopancreatectomy.
Klein M; Warschkow R; Ukegjini K; Krstic D; Burri P; Chatziisaak D; Steffen T; Schmied B; Probst P; Tarantino I
Langenbecks Arch Surg; 2024 May; 409(1):155. PubMed ID: 38727871
[TBL] [Abstract] [Full Text] [Related]
18. A Competing Risk Nomogram for Prediction of Prognosis in Patients With Primary Squamous Cell Thyroid Carcinoma.
Tian Y; He L; Zhang B; Deng L; Wang J
Technol Cancer Res Treat; 2024; 23():15330338241254059. PubMed ID: 38725285
[No Abstract] [Full Text] [Related]
19. Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of Pancreatic Carcinomas: In Search of Therapeutic Targets.
Faber EB; Krause HB; Amin K; Walker P; Hosein PJ; Shields AF; Lenz HJ; Prakash A; Goel S; Oberley M; Malleo G; Luchini C; Hwang J; Florou V; Garrido-Laguna I; Lou E
JCO Precis Oncol; 2024 May; 8():e2300595. PubMed ID: 38723231
[TBL] [Abstract] [Full Text] [Related]
20. [Analysis of factors affecting the prognosis of patients with pancreatic cancer patients with obstructive jaundice].
Zhang L; Li M; Sun QF; Yu HP
Zhonghua Nei Ke Za Zhi; 2024 May; 63(5):474-479. PubMed ID: 38715484
[No Abstract] [Full Text] [Related]
[Next]